📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Response to comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics". (2021)

First Author: Bovijn J

Attributed to: China Kadoorie Biobank (CKB) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abf4530

PubMed Identifier: 34851696

Publication URI: http://europepmc.org/abstract/MED/34851696

Type: Journal Article/Review

Volume: 13

Parent Publication: Science translational medicine

Issue: 622

ISSN: 1946-6234